Urology

 

Between physicians and payers: Physician executive in dual role seeks to build trust

October 01, 2006

Paul Handel, MD, has enjoyed a long, distinguished career as a physician in Texas, and now he wears two distinctive hats-neither of which is a Stetson.

Built to scale: Ed Sellers leads BlueCross BlueShield of SouthCarolina

May 01, 2006

Every time a new stop light goes up in a growing neighborhood,BlueCross BlueShield of South Carolina (BlueCross) wants to have acustomer within a block of it. This health plan, nested withsubsidiary businesses, has prioritized growth through an aggressivebranching out from its core competencies. Half of its totalbusiness comes from selling products to other healthcareorganizations.

Built to scale: Ed Sellers leads BlueCross BlueShield of SouthCarolina

May 01, 2006

Every time a new stop light goes up in a growing neighborhood,BlueCross BlueShield of South Carolina (BlueCross) wants to have acustomer within a block of it. This health plan, nested withsubsidiary businesses, has prioritized growth through an aggressivebranching out from its core competencies. Half of its totalbusiness comes from selling products to other healthcareorganizations.

February 2006 FDA Pipeline

February 01, 2006

New molecular entities

February 2006 FDA Pipeline

February 01, 2006

New molecular entities

Coming to Terms

December 01, 2005

Just mentioning "contract negotiations" can put plans and providers on the defensive or maybe even the offensive. The sometimes-contentious relationship between the two, triggered by the high cost of healthcare and complaints from providers about not being paid enough, escalates while both parties try to come to some kind of agreement.

Enhance efficiencies through shared emergency room data

October 01, 2005

The high cost of emergency department (ED) care is a concern for commercial and government insurers, hospitals, physicians and patients. Two-thirds of EDs operate at full capacity or over capacity, a situation exacerbated by increased ED visits from both insured and uninsured patients. Software applications that automate the ED can help improve patient outcomes and reduce costs. Payer organizations should be aware of four key adoption trends in ED automation.

DM Web site goes beyond national guidelines to include real-world ideas

October 01, 2005

While healthcare is highly competitive from a business perspective, when it comes to the actual delivery of care, everyone is on the same team. The ultimate goal is to provide the best possible care at the lowest possible cost, and that's exactly why the Cleveland Clinic created its Disease Management Project.

Drug advertising guidelines draw criticism

September 01, 2005

Critics contend that DTC promotion boosts medical costs.

Managing the Costs of Injectable Therapies: Do You Have the Right Game Plan? (PDF)

April 01, 2005

About three years ago I asked a large group of health plan executives if they knew how much they spend annually for ?specialty pharmacy? products. Few could respond, and virtually none had launched any efforts to control the then unknown rapid increase in these costs.Today, this is not the case.

Feb. FDA Pipeline

February 01, 2005

New entities and actions in brief

January FDA Pipeline

January 01, 2005

New molecular entities

On Finance: Costly pain of fibromyalgia can be reduced with holistic treatment

September 01, 2004

Fibromyalgia is real and prevalent, yet many physicians and employers may inadvertently ignore or demean sufferers, not only at the cost of those with the condition, but at the cost of productivity and healthcare expenditures.

August FDA Pipeline

August 01, 2004

FDA actions and new molecular entities

Skirmishing continues over drug importing

August 01, 2004

Washington, D.C. - Last month, the House approved legislation that would make it easier for Americans to obtain prescription drugs from Canada and other countries, similar to action it took last year. This time the legislators voted overwhelmingly to add to FDA's 2005 budget bill a provision that blocks FDA from enforcing a ban on drug reimportation. The drug import language is not expected to survive House-Senate negotiations on a final FDA spending bill, but it allows members of Congress to portray themselves as import advocates at election time.

January 2004 FDA Pipeline

January 01, 2004

New molecular entities, new biologics and new formulations

Reader Response to 'ER is a Hit '

December 10, 2003

Our recent "ER is a Hit With Insured Americans" news item stirred up some reader response.

November FDA Pipeline

November 01, 2003

Recent approvals and FDA actions

Benchmarking helps attain the delicate balance between cost and quality

September 01, 2003

Data allow MCOs to evalutate their pharmacy services and which drugs should or should not be covered

News & Trends

August 01, 2003

New HEDIS measures for 2004; President&s New Freedom Commission on Mental Health report; The Commonwealth Fund's report on eroding retiree benefits